Nautilus Biotechnolgy, Inc. Common Stock

NAUTNASDAQ • USD
ThemeGenomics & Precision Med.›Precision Medicine Platforms
1.96 USD
↘ 0.31 (13.60%)🟢LIVE (AS OF 09:44 AM EDT)
🟢Market: OPEN

Nautilus Biotechnolgy, Inc. Common Stock (NAUT) trades at $1.96 per share. Technicals currently rate "Sell" while our fundamental analysis reads "Neutral". Key drivers include a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On the valuation side, NAUT appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Jun 25, 2026.

Open?$2.30
High?$2.34
Low?$1.88
Prev. Close?$2.27
Volume?182.6K
Avg. Volume?427.3K
VWAP?$2.03
Rel. Volume?0.43x
Bid / Ask
Bid?$1.86 × 100
Ask?$2.85 × 100
Spread?$0.99
Midpoint?$2.36
Valuation & Ratios
Market Cap?288.5M
Shares Out?127.1M
Float?41.1M
Float %?32.3%
P/E Ratio?N/A
P/B Ratio?2.00
EPS?-$0.45
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.
Themes
Healthcare - Genomics & Precision Medicine›Precision Medicine PlatformsMedical Devices & HealthTech›Diagnostic Imaging & Equipment
Employees
130
Market Cap
299.9M
Industry
LABORATORY ANALYTICAL INSTRUMENTS
Website
www.nautilus.bio
Listed
2021-06-10
Address
2701 EASTLAKE AVE EAST
SEATTLE, WA 98102
Phone: 206-333-2001
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
31
Momentum?
50
Short Sent.?
100
Piotroski F-Score?0/9Weak
Altman Z-Score?1.88Grey
Confidence?45%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?1.32%Low
Short Interest?541.1K
Days to Cover?1.3
Free Float41.1M
Avg Daily Volume407.8K
Settlement Date2026-06-15
Financial Health
Current Ratio?11.85Strong
Quick Ratio?11.85Strong
Cash Ratio?1.75Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
74
2.00CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-4.4CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-39.5%WEAK▾
ROA?
S&P
3
-32.1%WEAK▾
Cash Flow & Enterprise
FCF?$-51427000
Enterprise Value?$273.8M
Fundamentals ratios updated end of day
MarketsMoversWatchlist